Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50% : insights from the pembrolizumab 5-year global registry
Alessio Cortellini, Valentina Santo, Leonardo Brunetti, Edoardo Garbo et autres
us, gb, br, it, my, de, ch, gr, pl, ie, fr, es (code pays fourni par la source)